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Abstract
The integrated stress response (ISR) maintains proteostasis by modulating protein synthesis and 
is important in synaptic plasticity, learning and memory. We developed a reporter (SPOTlight) 
for brain-wide imaging of ISR state with cellular resolution. Unexpectedly, we found a class 
of neurons in mouse brains, striatal cholinergic interneurons (CINs), in which the ISR was 
activated at steady-state. Genetic and pharmacological manipulations revealed that ISR signaling 
was necessary in CINs for normal type 2 dopamine receptor (D2R) modulation. Inhibiting the ISR 
inverted the sign of D2R modulation of CIN firing and evoked dopamine release and altered skill 
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learning. Thus, a non-canonical, steady-state mode of ISR activation is found in CINs and the ISR 
plays a neuromodulatory role in learning.
Graphical Abstract
One sentence summary:
Striatal cholinergic interneurons have high steady-state ISR activation that regulates dopamine 
modulation and skill learning.
The integrated stress response (ISR) is a highly conserved mechanism for cells to restore 
homeostasis in the face of diverse stressors, from unfolded proteins to nutrient deficiencies 
(1, 2). In the brain, regulation of protein synthesis by the ISR pathway is also required 
for long-term memory and synaptic plasticity (3–5). These key roles in the cellular stress 
response and learning and memory have attracted significant attention to the potential for 
the ISR as a therapeutic target in a wide range of human diseases including cognitive, 
neurodegenerative, movement, and substance use disorders (6–15).
Under healthy conditions, ISR signaling has canonically been understood as a temporary 
process controlled by the phosphorylation state of eukaryotic initiation factor 2 alpha 
(eIF2α). Eukaryotic IF2 is a ternary complex of α, β, and γ subunits that is required for 
protein synthesis initiation by enabling the binding of methionyl-tRNA to the ribosome in 
a GTP-dependent manner. Four dedicated eIF2α kinases (PERK, HRI, PKR, and GCN2) 
respond to different stressors by phosphorylating eIF2α at serine 51 (16). Kinase activity 
is balanced by two phosphatase complexes that share a common catalytic core, protein 
phosphatase 1 (PP1), but contain different regulatory subunits (GADD34 or CReP) that 
confer specificity for eIF2α. Phosphorylation of eIF2α causes dramatic shifts in protein 
synthesis. The bulk of protein synthesis is decreased; however, this overall reduction is 
accompanied by increased translation of a subset of mRNAs that contain upstream open 
reading frames (uORFs), most notably ATF4 (1, 17–19).
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While the translational consequences of ISR activation may have enduring effects 
dictated by the half-lives of the newly synthesized proteins, under normal conditions 
eIF2α phosphorylation itself is transient. To date, conventional approaches such as 
immunohistochemistry (IHC) have failed to capture these dynamic ISR signaling events, and 
present technical challenges including low throughput and modest antibody performance. To 
overcome this problem, we developed a reporter to reveal the translational state of the ISR 
pathway in brain cells.
With this reporter, we made the surprising discovery that, in contrast to the usual 
paradigm of stressor/stimulus-induced ISR activation, the ISR was constitutively activated 
in a subset of CNS neurons, striatal cholinergic interneurons (CINs). Using cell-selective 
manipulations, we then showed that the level of CIN ISR activation was activity-dependent, 
determined how D2R modulates CIN firing and striatal dopamine release, and changed 
performance of learned tasks. Our CIN-specific behavioral effects also reproduced some of 
the findings previously described with systemic ISR inhibition (20–22), indicating that ISR 
signaling in neuromodulatory cells is at least one of the cellular targets contributing to the 
enhanced learning effects associated with ISR inhibition.
SPOTlight reporter measures ISR state-dependent protein synthesis
We aimed to create a reporter with single-cell resolution that conveys information 
about the relative abundance of translation driven by eIF2α in its phosphorylated and 
unphosphorylated forms – essentially creating a thermometer-like scale for eIF2α phospho­
state-dependent contributions to the proteome. Because activation of the ISR leads to 
differential usage of uORFs in the 5’ UTR of Atf4 mRNA (19, 23), we inserted green 
and red fluorophores into distinct but overlapping reading frames. With this design, one of 
the two fluorophores would be translated, mutually exclusively, based on ISR activation state 
(Fig. 1A). We named the reporter SPOTlight, for Selective Phospho-eIF2α ORF Tracking 
light. SPOTlight expresses tdTomato from the Atf4 start codon, which is translated when 
the ISR is activated (high p-eIF2α). The coding sequence for a contrasting fluorophore, 
EGFP, was placed in uORF2, which is translated under conditions of low p-eIF2α. Thus, 
using a single reporter we could monitor translation when the ISR was activated or inactive. 
We then packaged the reporter construct into an AAV bearing the PHP.eB capsid to allow 
efficient brain-wide transduction in mice after a simple retro-orbital injection (24) (Fig. 1B). 
Importantly, Atf4 mRNA is ubiquitously expressed throughout the body, and Atf4 regulatory 
uORFs are conserved from invertebrates to mammals (17, 18). Thus, the SPOTlight reporter 
can be adapted for use in a wide array of species and contexts after simple changes to viral 
packaging and delivery.
We expected that the non-phosphorylated eIF2α state would predominate under basal 
conditions, and lead to EGFP translation and green fluorescence. In contrast, increased 
translation of tdTomato would be expected when eIF2α is phosphorylated, such as under 
conditions activating the ISR (17, 18). Indeed, brain-wide, the SPOTlight EGFP signal 
predominated, whereas tdTomato signal was lower, even when amplified by anti-RFP 
labeling (Fig. 1C, D). Although rare, occasional cells with significant red fluorescence were 
found, for example, among hippocampal pyramidal neurons and cerebellar Purkinje cells 
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(Fig. 1E). These sparse cells likely reflected stochastic ISR pathway activation owing to cell 
stress or other activators.
To test the relationship between SPOTlight fluorophore expression, ISR activation, and 
eIF2α phosphorylation, SPOTlight-expressing mice were treated with tunicamycin (Tm), a 
potent activator of the PERK branch of the ISR (Fig. 1B). As expected, acute systemic 
in vivo Tm exposure significantly increased tdTomato fluorescence 8 hr post-injection 
(Fig. 1F,G; Tm: 296.7 ± 45.7% of Veh, p=0.0015), consistent with predictions that eIF2α 
phosphorylation levels would rise after an ISR trigger (1). To establish whether the Tm­
evoked tdTomato increase required p-eIF2α, we used a pharmacological inhibitor, ISRIB, 
which blocks the downstream translational effects of eIF2α phosphorylation (20, 25). When 
ISRIB was given prior to Tm, tdTomato intensity was significantly lower (Fig. 1F,G; Tm: 
296.7 ± 45.7% of Veh v. ISRIB/Tm 126.6 ± 34.3% of Veh, p = 0.0242), while administration 
of ISRIB alone did not significantly alter tdTomato levels compared to vehicle control (Fig. 
S1A-C; 78.9 ± 14.4% of Veh, p=0.4269). The potent ISR induction by Tm also provided 
an ideal opportunity to establish the relationship between tdTomato intensity and p-eIF2α 
(ISR activation) levels. p-eIF2α levels increased in parallel with tdTomato signal in virally 
transduced cells (Fig. 1F, Fig. S2; Tm: 149.9 ± 10.3% of Veh, p=0.0001; Pearson correlation 
coefficient r=0.8296). We found no significant difference in p-eIF2α immunofluorescence 
between vehicle and ISRIB alone (Fig. S1C; p=0.5142). Thus, as predicted, SPOTlight 
mRNA translation was controlled by the ISR.
Tonically active cholinergic interneurons show steady-state ISR activation
In the striatum, we observed that the sparse red cells did not seem to be stochastic (as 
observed in CA2 and Purkinje cells), but rather corresponded to a specific cell subtype 
that uniformly and strongly expressed SPOTlight tdTomato. Based on their distinctive 
morphology, we suspected these cells might be striatal cholinergic interneurons (CINs) 
and performed IHC with a cholinergic interneuron-specific marker, choline acetyltransferase 
(ChAT). Indeed, although striatal projection neurons (SPNs) were successfully transduced 
by AAV-PHP.eB (Fig. S3), tdTomato signal was highly correlated with expression of choline 
acetyltransferase (ChAT), but not the SPN marker DARPP32 (Fig. 2A). To further support 
these findings, we directly measured p-eIF2α levels in CINs and SPNs by IHC. Cytoplasmic 
p-eIF2α intensity was elevated more than 25-fold in CINs (ChAT+) compared to SPNs 
(DARPP32+) (Fig. 2B-C). To assess how widespread elevated p-eIF2α levels were among 
CINs, we defined “background” p-eIF2α intensity as the mean value observed in SPNs. 
Compared to this baseline, greater than 90% of CINs, but less than 5% of SPNs, had 
elevated p-eIF2α (>2 SD; n= 92 CINs and 395 SPNs from three C57Bl/6 mice). Significant 
differences between CINs and SPNs were also observed using measures of two other ISR 
components – upstream activation of the PERK branch of the ISR, and the downstream 
consequences on Atf4 transcription (Fig. S4). Thus, the high SPOTlight-tdTomato signal 
in CINs corresponded with multiple measures of ISR pathway activity, supporting the 
unexpected conclusion that in CINs, the ISR was constitutively activated at steady state.
Relative to other striatal neurons, CINs are notable for their tonic action potential firing. 
Because increased neuronal activity is the presumptive trigger for eIF2α phosphorylation 
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during synaptic plasticity (4), we hypothesized that tonic action potential firing in CINs 
might be the cellular trigger for ISR activation. To test this hypothesis, we chronically 
suppressed CIN activity using the inhibitory DREADD hM4Di (26, 27). Briefly, ChAT­
Cre mice were transduced with AAVs that Cre-dependently express hM4Di-mCherry 
or mCherry alone. After administering the DREADD-specific ligand, clozapine N-oxide 
(CNO), twice daily for 5 days, IHC revealed that Gi/o DREADD activity significantly 
reduced p-eIF2α and p-PERK levels in CINs compared to the mCherry control (Fig. 2D-E 
and Fig. S4, respectively). Thus, CIN activity is a driver of steady-state ISR activation in 
these cells.
To survey whether there were other neuronal subtypes with high basal ISR demand, we used 
SPOTlight and found a tendency for other high-firing cell types to have higher proportions 
of cells with red-dominant SPOTlight signal, but none had a cell class-wide effect like CINs 
(Fig. S5). Although the AAV PHP.eB serotype is useful to easily sample neurons and glia 
brain-wide, our cell survey is limited to its viral tropism. For other specific cell populations, 
dedicated studies delivering SPOTlight with methods that efficiently target those cells will 
be necessary.
ISR state of cholinergic interneurons determines sign of CIN D2R 
modulation
We next sought to understand the functional significance of constitutive ISR activation in 
CINs. The ISR is known to be required for long-lasting forms of synaptic plasticity (3, 4, 
28), including long-term depression at cortico-striatal synapses on striatal projection neurons 
(c-s LTD) (6). Modulation of CIN activity via the type 2 dopamine receptor (D2R) is also 
required for the induction of c-s LTD at SPN synapses (29, 30). D2R signaling transiently 
lowers tonic CIN action potential firing (31) and this D2R-mediated “pause” is thought to 
play a necessary and permissive role for induction of c-s LTD in SPNs (32, 33). These 
associations led us to wonder whether pharmacological and genetic inhibition of the ISR 
would affect D2R-mediated modulation of CINs.
To answer this question, we performed cell-attached recordings of CINs in acute brain slices 
and evaluated responses to the D2R agonist, quinpirole (QUIN) (Fig. 3A,B). Compared to 
control slices (VEH), slices pre-incubated with the ISR inhibitor, ISRIB, showed significant 
differences in QUIN rate modulation (Fig. 3C-E). This QUIN effect was blocked by the 
D2R antagonist, sulpiride (Fig. S6), which suggests that it involved D2R actions.At the 
group level, ISRIB caused a net increase in CIN firing, effectively inverting the sign of D2R 
modulation (Fig. 3E). Consistent with these results, the PERK antagonist, AMG PERK 44, 
also inverted the normal D2R response (Fig. 3F-H). We next tested the D2R response in 
phospho-mutant Eif2s1S/A mice, which exhibit a genetic haplo-insufficiency for the eIF2α 
phosphorylation site (S51A) (34) and reduced brain levels of p-eIF2α (21). Accordingly, 
genetic inhibition of the ISR also caused a net increase in CIN firing rate in response to 
QUIN (Fig. S7). Thus, genetic or pharmacological inhibition of the ISR profoundly changes 
the nature of D2R modulation of CIN firing by causing a rate increase instead of decrease.
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Because a full understanding of how the ISR regulates neuromodulatory state requires its 
dissection at the cellular level, we developed a molecular genetic approach to inhibit the 
ISR in a cell-type specific manner. The p-eIF2α phosphatase, CReP, was expressed in a Cre­
dependent manner using a viral vector (AAV-DIO-CReP; see Fig. 3A schematic for CReP in 
ISR pathway). We then injected AAV-DIO-CReP into the dorsal striatum of ChAT-Cre mice 
(Fig. 3I). Using p-eIF2α IHC, we first confirmed that expression of CReP in this manner 
was sufficient to lower p-eIF2α levels in CINs (Fig. 3J,K). We then tested responses to 
quinpirole and found that CReP overexpression in CINs disrupted D2R modulation similarly 
to the global pharmacological and genetic manipulations (Fig. 3L-N). Lastly, although some 
ISR manipulations altered basal CIN firing rates (e.g. Fig. 3D lowers, Fig. 3M increases), 
there was no consistent relationship between basal firing rates that could explain D2R CIN 
modulation effects (Fig. S8). Thus, ISR activity is specifically required within CINs for 
normal D2R modulation of CIN firing.
We next examined which CIN conductances might be altered by ISR activity to cause 
the D2R-dependent CIN firing differences. Using whole cell current-clamp recordings to 
examine current-voltage (I-V) relationships, we surveyed properties of intrinsic membrane 
excitability and action potential (AP) waveforms (Table S1). ISR inhibition by ISRIB 
reduced the magnitude and duration of the medium afterhyperpolarization (mAHP) 
component of the AP (Fig. S9A-C, Table S1). We thus hypothesized that the ISR may 
regulate SK channel activity because SK channels are the major contributor to the mAHP 
in CINs (35, 36). To directly test the role of SK channels, we bidirectionally manipulated 
SK channel activity. First, we tested the effects of an SK channel antagonist, apamin, on 
the D2R response of CINs. Apamin was sufficient to reproduce the D2R response inversion 
associated with ISR inhibiting manipulations (Fig. S9D-F). To test whether reduced SK 
activity was required for ISRIB’s actions, we compared ISRIB’s actions in the presence 
or absence of an SK channel positive allosteric modulator, CyPPA. CyPPA significantly 
blocked ISRIB’s effects, indicating that SK activity reduction is also necessary (Fig. S9G-I). 
Thus we suggest a molecular model in which the ISR regulates SK channel activity and the 
mAHP to influence the CIN firing response to D2R agonism.
We next examined whether CIN ISR activity had consequences on striatal dopamine release 
because striatal cholinergic signaling is a well-known regulator of dopamine release (37). 
Evoked dopamine (DA) transients were detected using the dLight1.2 fluorescent reporter 
(38) in response to intra-striatal electrical stimulation in acute brain slices. In control slices, 
D2R antagonism by sulpiride increased evoked dLight responses (Fig. 4B), indicating that 
the net effect of striatal D2R contributions was to depress DA release (Fig. 4C,D). In marked 
contrast, sulpiride reduced evoked dopamine transients in ChAT Cre/DIO-CReP slices (Fig. 
4B), indicating that when the ISR was inhibited in CINs, the net D2R effect was to enhance 
DA release (Fig. 4C,D). These results are consistent with what would be predicted from 
the known effects of CIN activity on dopamine release (37, 39) combined with our finding 
that ISR inhibition causes D2R signaling to increase, rather than decrease, CIN firing (Fig. 
3). Thus, genetic, pharmacological, and cell-specific manipulations clearly demonstrate that 
ISR activity in CINs is necessary for the integrity of dopamine D2R modulation, with both 
cell autonomous and circuit-level consequences.For both effects ISR inhibition effectively 
inverts the normal sign of D2R-mediated modulation.
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ISR state of CINs regulates skill learning
Striatal integration of cholinergic and dopaminergic signaling is central to sensorimotor 
learning and motor skill performance (32, 40). In prior studies, enhanced performance in 
learning tasks has been observed with systemic or brain-wide ISR inhibition (20–22). We 
thus asked whether ISR activity in CINs might be a target for some of these behavioral 
outcomes. Accordingly, we genetically lowered ISR activity in dorsal striatal cholinergic 
interneurons by injecting AAV-DIO-CReP or control AAV into the dorsal striatum of 
ChAT-Cre mice (Fig 5A). Viral spread was documented post-mortem and expression within 
ChAT+ cells confirmed by IHC for the Myc-tag and p-eFI2α (Fig. S10).
Following three weeks of viral expression, mice were tested using the same Morris water 
maze (MWM) training protocol that previously showed enhanced learning with systemic 
ISRIB treatment (20). Mice with CIN-CReP overexpression reached the hidden platform 
faster (Fig. 5B), reproducing results from prior systemic genetic and pharmacological ISR 
manipulations (20–22). We further found that the effect was sex-dependent (males only) 
(Fig. S11) and prior reports were of all male cohorts (20–22). Lastly, memory effects 
measured by the probe test performed on day 3 of training showed similar trends as prior 
reports but suffer from being underpowered owing to the sexually divergent effects (Fig. 
S11). We thus tested independent cohorts of mice using an orthogonal assay for motor 
skill learning, a lever press task that we have not found to have significant sex-related 
effects (41). Mice were trained to press a lever for a food pellet reward through a series of 
increasingly delayed reward contingencies, as previously described (41). In the lever press 
task, CIN-CReP overexpressing mice again outperformed control mice, showing higher 
lever press rates (Fig. 5C and S12). Furthermore, the performance differences once again 
emerged over time and were not present at the onset of training, consistent with effects on 
skill learning.
The specific lever press training protocol we used promotes habit learning (41) and lever 
press rates can be influenced by training paradigms associated with goal-directed or habitual 
behavior (42, 43). We thus tested whether deficits in habit learning might explain the 
learning curve differences. To this end, we employed a probe test for habitual behavior, 
which measures the persistence of lever pressing when the reward is absent and has 
been devalued by pre-feeding. However, we found no evidence for any effects of CIN­
specific CReP overexpression on habit learning (Fig. 5D). We also found that CIN-CReP 
overexpression in the targeted dorsal striatal region did not alter rotarod performance or fear 
conditioning (Fig. S13).
Given known contributions of dopamine and dorsal striatal circuits to performance vigor 
(44, 45), we wondered whether the performance effects in the Morris water maze and lever 
press task might relate to a common effect on speed/vigor. We performed sub-analyses 
to address this possibility and found that the Morris water maze results did appear to 
be driven by effects on swim velocity. Male CIN-CReP OE mice learned to swim with 
higher velocities than controls (Fig. 5F). We also found that the faster lever press rates that 
emerged with training in CIN-CReP OE mice were accompanied by a skewed distribution 
towards shorter inter-press intervals (Fig. 5E). Lastly, we examined whether the mice were 
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hyperactive in general, by monitoring locomotion in an open field (OF) apparatus. In 
contrast to the behavioral differences that emerged in the skill learning tasks, CIN-CReP 
overexpression had no effect on locomotor speed in an untrained, exploratory behavior 
test (Fig. 5G). Thus, ISR signaling in striatal cholinergic interneurons influences the vigor 
of learned tasks. In addition, because our CIN-specific results reproduce some behaviors 
previously elicited by systemic ISR inhibition, striatal cholinergic interneurons represent an 
underlying cellular target for at least some of the learning enhancement effects.
Conclusions
Here we discovered a role for the ISR in brain function -- neuromodulation. ISR activity in 
CINs powerfully regulates dopamine modulation and learned skill. Furthermore, we found 
that striatal cholinergic interneurons as a class are distinct from most neurons in that they 
show constitutive activation of the integrated stress response. This basal ISR activation 
in CINs is dependent on tonic firing activity. CIN ISR signaling influences the D2R­
mediated firing response by establishing basal intrinsic membrane excitability properties. 
The consequences of CIN ISR signaling markedly shape D2R-mediated dopamine release in 
striatal circuits, and the degree of vigor in learned task performance.
By developingSPOTlight to assess ISR state-dependent translation brain-wide (, we were 
initially led to the surprising discovery of rare cell types with high levels of ISR activation at 
steady state. The existence of cell types with a chronic basal demand for ISR activity carries 
significant implications for their potential vulnerability to ISR-inhibiting states, whether due 
to environmental, genetic, or pharmacological causes. Moreover, sex differences observed 
with CIN ISR inhibiting manipulations in both behaviors suggest that sexually dimorphic 
biology may determine sensitivity to ISR state.
Although we focus on cholinergic interneurons in this study because CINs show a striking 
population-wide engagement of the ISR basally, SPOTlight revealed a number of other 
cell types with at least portions of the population denoting ISR activation. Examining the 
significance of ISR activation in these cell subsets may reveal additional ISR roles. Indeed, 
recent studies in circadian rhythms and axon guidance highlight the potential for more 
diverse neuronal roles of ISR signaling in the brain (10, 46). Our conclusions regarding the 
behavioral significance of the ISR in CINs are restricted to the portion of dorsal striatal 
cholinergic neurons manipulated. Manipulating the ISR in other cholinergic populations will 
be necessary to test additional contributions, such as to motivational salience in ventral 
striatal populations (47, 48). Lastly, the ISR has been variously implicated as a candidate 
mechanism and/or therapeutic target for a number of human diseases, including dystonia, 
neoplastic, neurodegenerative, and cognitive disorders (6–15, 49). In such disease states, 
SPOTlight may help identify critical sites and time windows of ISR dysregulation.
Our findings expand the understanding of where and how the ISR acts to influence learning 
and memory behavior. The ISR plays a steady-state role in striatal CINs that determines the 
neuromodulatory state of the striatal circuitry, with behavioral consequences that negatively 
constrain the vigor of learned tasks. ISR inhibition has previously been associated with 
enhanced task learning and long-term potentiation (LTP). Here we show that ISR activity 
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in striatal cholinergic neurons underlies at least some of the enhanced learning effects of 
systemic ISR inhibition (20–22). In addition, interpretation of the ISR site of action for 
long-term synaptic plasticity has focused on mechanisms such as local regulation of protein 
synthesis in the potentiated/depressed cell (4, 28, 50). However, given that many forms of 
synaptic plasticity and learning and memory are heavily influenced by neuromodulation 
from dopamine and/or acetylcholine (29, 51–54), our results prompt further examination 




All experimental procedures were approved by the Institutional Animal Care and Use 
Committee at Duke University. Sample size was based on the ARRIVE recommendations. 
All animals were maintained on a 12:12 light-dark cycle with ad libitum access to food 
and water. C57Bl/6J mice and IRES-Cre ChAT-Cre mice (JAX: 006410) were obtained 
from Jackson laboratories. Eif2s1 S51A mice (34) were maintained on a C57Bl/6J 
background. For slice-electrophysiology, homozygous IRES ChAT-Cre mice were crossed 
with homozygous Ai3 reporter mice on the Rosa26 locus (JAX: 007903) to yield double 
heterozygotes with EYFP-expressing cholinergic interneurons. Juvenile (P21–60) male and 
female mice were utilized for slice electrophysiology; whereas, adult male and female 
mice aged 10–12 weeks were used for viral injections, and subsequent behavior or 
immunohistochemistry was performed on mice aged 14–25 weeks.
Genotyping
Toes were collected between P7-P14 for genotyping and the following primers were used:
Ai3: WT forward 5’-AAG GGA GCT GCA GTG GAG TA-3’; WT reverse 5’-CCG AAA 
ATC TGT GGG AAG TC-3’; Mutant forward 5’ACA TGG TCC TGC TGG AGT TC-3’; 
Mutant reverse 5’-GGC ATT AAA GCA GCG TAT CC-3’. Eif2s1 (S51A): Forward: 
5’CAC ACA CCC ATT CCA TGA TAG TAA ATG-3’; Reverse 5’-CAA TGT TGT AGA 
CCC TGA CAA TGA AGG-3”. Sequencing for ChAT-Cre genotype was performed by 
Transnetyx, Inc (Cordova, TN) using real-time PCR according to methods described in (55).
Viral Constructs
The recombinant Adeno-associated viral (AAV) construct, SPOTlight was developed in the 
lab consisting of recombinant DNA manufactured based on the known published sequence 
of murine activating transcription factor 4 (Atf4) mRNA (NCBI Reference Sequence: 
NM_009716.3) by Vector Builder (https//en.vectorbuilder.com/) and cloned into an AAV 
vector carrying the CMV early enhancer/chicken beta-actin (CAG) promoter. The vector 
construct was then packaged into a PHP.eB capsid (24) by the Duke Viral Vector Core. 
The final concentration was 3.0 × 1013 genome copies per mL. An AAV vector construct 
containing the EGFP fluorophore with the CAG promotor packaged in the PHP.eB capsid, 
viral concentration 2.0 × 1013 genome copies per mL, was used as a control.
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The Cre-activated recombinant AAV-construct, AAV5-hSYN-DIO-mCReP termed “CReP 
OE” virus, was developed in the lab and packaged by the Duke Viral Core. A double­
floxed inverted orientation (DIO) construct was synthesized containing two pairs of 
incompatible Lox sites (LoxP and Lox2722) and the Ppp1r15b gene manufactured based 
on the known published sequence of mouse protein phosphatase 1, regulatory subunit 15b 
(Ppp1r15b) mRNA (NCBI Reference Sequence: NM_133819.3) by Vector Builder (https//
en.vectorbuilder.com/) was inserted between the LoxP and Lox2722 sites in the reverse 
orientation, and cloned into a vector carrying the neuronal-specific human synapsin 1 
(hSYN) gene promotor. The new vector construct underwent quality control testing with 
DNA quantification, restriction enzyme digestion, and Sanger sequencing. The resulting 
vector was then serotyped with AAV5 coat proteins and packaged by the Duke Viral Vector 
Core. The final viral concentration was 1.0 × 1013 genome copies per mL.
Viral Injections
AAV-PHP.eB-CAG-SPOTlight virus was administered by retro-orbital injection in 10–12 
week old C57Bl/6J mice that were anesthetized with isoflurane until absent paw-pinch 
response and then rapidly injected behind the orbit with 10 μL of virus diluted in 40 μL of 
0.2 micron sterile-filtered phosphate-buffered saline (PBS) for a total injection volume of 50 
μL with a single use 0.5 mL insulin syringe (BD) and then monitored through recovery from 
anesthesia for return to normal activity. Post-procedure analgesia with one to two drops of 
Bupivacaine ophthalmic solution was applied.
Ten to twelve-week-old ChAT-Cre heterozygous mice received either an intracranial 
injection of double floxed reversed rAAV5-hSYN-DIO-mCReP at a 3:1 dilution with 
rAAV5-Ef1a-mCherry virus or control (3:1 dilution of 1× PBS vehicle to rAAV5-Ef1a­
mCherry virus). For stereotactic viral injections, mice were anesthetized with isoflurane and 
maintained under anesthesia during the entire procedure. While under anesthesia, mice were 
monitored visually, and depth of sedation ensured by absence of response to paw pinch. 
600 nL of virus was injected per hemisphere into the dorsal striatum (anteroposterior +0.5 
mm and 2 mm mediolateral from bregma) at two depths of −2.5 mm and −3.0 mm with a 
Nanoject III Programmable Nanoliter Injector at 2.5 nL per second. Experiments including 
behavioral analysis and immunohistochemistry were carried out three weeks later to allow 
for viral expression.
In vivo drug treatments
Tunicamycin dissolved in DMSO (5 mg/mL) was purchased from Millipore Sigma 
(St. Louis, MO) and diluted 1:25 (vol/vol) in 150 mM Dextrose to administer a final 
concentration of 3 μg/g bodyweight per mouse in a single i.p. dose. Vehicle controls 
were injected i.p. with 0.2 micron sterile-filtered DMSO diluted 1:25 (vol/vol) in 150 
mM Dextrose. Trans-ISRIB was purchased from Tocris Biosciences (Minneapolis, MN) 
dissolved in DMSO to 5 mM and then further diluted 1:10 (vol/vol) in 0.2 micron sterile­
filtered 1× PBS with Tween-80 to administer a final concentration of 2.5 mg/kg per mouse 
delivered by i.p. injection one hour prior to injection with tunicamycin or vehicle (1:10 
vol/vol DMSO to 1× PBS with Tween-80).
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For preparation of brain tissue for IHC, mice were anesthetized by aerosolized isoflurane 
and i.p. injection of 250 mg/kg Tribromoethanol (Avertin), followed by opening of the 
thoracic cavity and transcardial perfusion with 1× PBS followed by fixation with 4% 
paraformaldehyde. Perfused brains were carefully removed and stored in 4% PFA overnight, 
followed by 48 hours in 30% sucrose solution in 1× PBS for cryoprotection. Brains were 
frozen in OCT medium and sectioned using a Cryostat at a thickness of 30 microns for 
coronal sections or 60 microns for sagittal sections. Immunohistochemistry was performed 
on free-floating sections. Commercially available primary antibodies to rabbit anti-mouse 
p-eIF2alpha (1:100, Abcam, cat# ab32157; RRID: AB_732117), goat anti-mouse Choline 
acetyltransferase (ChAT) (1:200, Millipore, cat# AB144P; RRID: AB_2079751), chicken 
anti-mouse Tyrosine Hydroxylase (TH) (1:500, Abcam cat# ab76442; RRID: AB_1524535), 
goat anti-mouse DARPP32 (R&D Systems, cat# AF6259; RRID: AB_10641854), anti-Myc 
tag (1:200, Abcam, cat# ab9106; RRID: AB_307014), rabbit anti-mouse p-PERK (Thr980) 
(1:1000, Bioss, cat#Bs-3330R; RRID: AB_10855345), and rabbit anti-mouse RFP (1:1000, 
Rockland antibodies and assays, cat# 600–401-379; RRID: AB_2209751) or chicken 
anti-mouse RFP (1:500, Novus Biologicals, cat# NBP1–97371; RRID: AB_11139267) 
were used for these experiments. Corresponding secondary antibodies raised in donkey 
conjugated to either Alexa Fluor 488, Alexa Fluor 647, or Rhodamine Red were obtained 
from ThermoFisher Scientific (Invitrogen). Sections were washed three times with 1× PBS 
plus 0.3% Triton X-100 (PBS-T), blocked for 1 hour at RT in 10% normal donkey serum 
(NDS) + 1% bovine serum albumin (BSA), followed by incubation for 48 hours at 4°C with 
constant rotation on an orbital shaker in primary antibody diluted in 5% NDS in PBS-T. 
The sections were then washed three times with PBS-T and incubated for 1 hour at RT with 
corresponding secondary antibody in 5% NDS in PBS-T followed by two washes in PBS-T. 
Tissue sections were then mounted on slides, covered with Invitrogen SlowFade Diamond 
Antifade Mountant with DAPI (ThermoFisher Scientific), and cover-slips applied.
Image acquisition and processing
To obtain sagittal section images of SPOTlight (Fig. 1C,D), free floating sections were 
immunostained with primary antibody to red fluorescent protein which cross reacts with 
tdTomato followed by Rhodamine Red conjugated secondary antibody and then imaged 
using a Leica DMi8 Andor Dragonfly 505 unit with Borealis illumination spinning disk 
confocal microscope at 200× magnification. Post-image acquisition stitching was performed 
on a MSI – Aegis R desktop using Imaris Stitcher with positioning ascertained by the image 
metadata and post-stitched image processing was performed in FIJI/ImageJ 64
Imaging of samples involving IHC staining was performed using either the Zeiss Axio 
Observer for single plane images at 600X magnification or using a Leica Dmi8 Andor 
Dragonfly 505 unit with Borealis illumination spinning disk confocal microscope at 400X 
magnification for Z-stacks. Neuronal somatic fluorescent intensity was measured using FIJI 
analysis software (imagej.nih.gov) by generating a mask to the threshold intensity of the 
cellular marker (or EGFP for CA2 pyramidal cell and cerebellar Purkinje cell analysis) and 
selecting each individual soma as a region of interest (ROI) using the wand selection tool 
with the nuclei excluded. Corrected total cell fluorescence (CTCF) was calculated based on 
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the measured Integrated Density minus (Area of the selected cell x Mean fluorescence of 
background readings). For ratiometric analysis, acquisition of EGFP and RFP signal was 
performed at equal exposure lengths across fluorophores and post-processed in ImageJ using 
similar settings including background subtraction with rolling ball radius of 50.0 pixels and 
threshold set to EGFP signal. Masks to EGFP and tdTomato signal were generated and 
the wand selection tool was used to select regions of interest (individual soma with nuclei 
excluded). Data are shown as ratios of individual cell CTCF tdTomato/αRFP to CTCF of 
EGFP signal.
Gi DREADDs
Chemogenetic manipulation of CIN activity was achieved through stereotactic injection 
of 600 nL of rAAV9-hSyn-DIO-hM4Di mCherry Gi DREADD [plasmid: #44362] (56) 
or rAAV9-hSyn-DIO-mCherry control (DREADD naïve) [plasmid #50459] obtained from 
Addgene (Watertown, MA) into the dorsal striatum (anteroposterior +0.7 mm and 2.4 mm 
mediolateral to bregma at a depth of −3.0 mm) of 10–12-week old ChAT-Cre heterozygous 
mice. Three weeks after viral delivery, the DREADD agonist, clozapine N-oxide (CNO) 
was injected i.p. 3 mg/kg/day in two divided doses spaced 8 hours apart for 5 days. On the 
5th day, mice were sacrificed 60 minutes following the last dose of CNO by transcardial 
perfusion for subsequent immunohistochemistry.
Slice electrophysiology
Adult mice (3–8 weeks) were anesthetized and intracardially perfused with high-sucrose 
solution (194 mM sucrose, 30 mM NaCl, 4.5 mM KCl, 2 mM MgCl2, 0.2 mM CaCl2, 1.2 
mM NaH2PO4, 26 mM NaHCO3, and 10 mM glucose, saturated with 95% O2 and 5% 
CO2). Animals were then decapitated, their brains dissected, and 300 μm coronal slices were 
cut on a Leica VT1200S vibratome. Slices were transferred to artificial cerebrospinal fluid 
(ACSF; 124 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, 1.2 
mM NaH2PO4, and 10 mM glucose, saturated with 95% O2 and 5% CO2, pH 7.4, 300 
mOsm/l) containing test compound or vehicle control and allowed to equilibrate for at least 
1 h. Single slices were transferred to a recording chamber and superfused continuously with 
ACSF containing 50 μM picrotoxin at 32°C and 3–4 mL/min. Neurons were visualized 
using infrared differential interference microscopy. Micropipettes were pulled (Narishige pc 
100) from borosilicate glass tubes (King Precision Glass) for a final resistance of 3 – 4.5 
MΩ when filled with internal solution (130 mM KSO4CH4, 5 mM KCl, 5 mM NaCl, 100 
μM EGTA, 10 mM HEPES, 2 mM MgCl2, 50 μM CaCl2, 2 mM ATP-Mg, 400 μM GTP­
Na, pH 7.3, 290 mOsm/l). Cholinergic interneurons in the dorsolateral striatum were first 
recorded in cell-attached mode. After 15 min baseline recording in test compound/control, 
slices were treated with 10 µM quinpirole (a selective D2R agonist) (Tocris Bioscience, 
Minneapolis, MN) for 3 min and recorded for another 12 min thereafter. Afterwards, 
recording was switched to whole-cell configuration, and the standard I-V protocol was 
applied for electrophysiological properties to secondarily indicate cell-type. Firing rates 
were calculated from the 10 minute periods just prior to (“pre”) and immediately following 
(“post”) quinpirole addition.
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Drugs used for slice electrophysiology treatment were stored as stock solutions and working 
solutions were prepared prior to each experiment and added to the perfusion solution in 
the final concentration indicated. Apamin (100 nM; Cat. No. 1652); trans-ISRIB (50nM; 
Cat. No. 5284); AMG PERK 44 (100nM; Cat. No. 5517); CyPPA (20μM; Cat. No. 2953); 
(RS)-(±)-Sulpiride (5 μM; CAS 156–16-1) and (−)-Quinpirole hydrochloride (10 μM; Cat. 
No. 1061) from Tocris Bioscience (Bristol, UK). Picrotoxin (50 μM; CAS 124–87-8) from 
MilliporeSigma (St. Louis, MO).
AAV5-dLight 1.2 injections
Stereotaxic injections were carried out on 1–2 month-old ChAT-Cre mice under isoflurane 
anesthesia. Meloxicam (5 mg/kg) was administered subcutaneously after anesthesia 
induction for postoperative pain relief. Craniotomies were made over the injection sites 
and 600 nL virus were delivered bilaterally to dorsolateral striatum via a Nanoject III 
(Drummond Scientific) at a rate of 0.2 mL/min. Animals were injected with either 1:1 AAV5 
- dLight 1.2 (pAAV-hSyn-dLight1.2, Addgene 111068, 4.8*108 vg/hemisphere) and CReP 
OE virus (AAV5-hSYN-DIO-mCReP, 3*109 vg/hemisphere) or 1:1 AAV5 - dLight 1.2 and 
sterile filtered PBS. The injection pipette was held in place for 10 min following injection 
and then slowly removed. Coordinates for all injections relative to bregma were as follows: 
A/P: 0.9 mm, M/L: +/−2.35 mm, D/V: −3.3 and −3.0 mm (300 nL per depth).
dLight1.2 multiphoton imaging
To measure evoked dopamine release, ChAT-Cre animals previously injected with DLight1.2 
+/− CReP OE were sacrificed for slice imaging 3–4 weeks post injection. Experimenters 
were blinded to the viral injection the animals previously received. 300 µm acute coronal 
slices containing the striatum were prepared as described for electrophysiology with slight 
modifications; for these experiments, an N-methyl-D-glucamine (NMDG) based ACSF 
solution was used for perfusion, cutting, and an additional heated recovery step. NMDG 
ACSF contained (in mM) 90 NMDG, 2.5 KCl, 1.2 NaH2PO4, 35 NaHCO3, 20 HEPES, 
25 glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO4 heptahydrate, 
and 0.5 CaCl2 dihydrate. Immediately after cutting, slices were placed in a 32°C recovery 
chamber containing NMDG ACSF for 10–12 minutes. After heated recovery, slices were 
transferred to a chamber containing ACSF for 1 hour at room temperature prior to recording.
Following recovery, slices were placed in a perfusion chamber identical to those used in 
electrophysiology experiments and similarly superfused with oxygenated ACSF. Slices were 
visualized using a Bruker Investigator Multiphoton Imaging system under epifluorescence 
illumination to initially locate a region of interest. A concentric bipolar electrode (FMC) was 
placed in the dorsal striatum on the lateral side of the estimated dorsomedial/dorsolateral 
boundary.
After selecting a region of interest, subsequent imaging of dLight1.2 was performed using 
920 nm light emitted from a Coherent Comeleon I Ti:Sapphire femtosecond laser to excite 
dLight1.2 fluorophores. Laser intensity was kept constant across all experiments. Resonant 
scanned 512 × 512 rasters of the entire FOV were imaged at 30Hz. Fluorescence signal was 
collected using a Nikon CFI75 LWD 16X W Objective and Quad GaAsP PMTs. Sample 
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signal was split into red and green channels via a 565lpxr dichroic mirror; dLight1.2 signal 
was isolated using a 525/70 bandpass PMT filter. ROI selection was refined in real time 
to maximize visualization of evoked dLight1.2 responses estimated using a single 900 uA 
electrical test pulse. Electrical stimuli were delivered using an ISO-FLEX Stim Isolation 
Unit.
Stim-pulse experiments were comprised of repeated 15 × 5 second (150 frames) imaging 
epochs paired with an electrical pulse (900 uA, 0.3 ms duration) 1 second following the 
start of image capture. Pulses consisted of, in order, a single stimulation, a 2 Hz, 5 Hz, 
and 100 Hz stim train (5 pulses each), and a second single pulse. Each stimulation pulse 
was performed in triplicate for a total of 15 stimulations per condition, and each epoch 
was separated by a one-minute inter-stim interval. Following acquisition in vehicle (ACSF) 
conditions, 5 uM sulpiride (Tocris) was added to the chamber and allowed to perfuse for five 
minutes prior to performing a second imaging sequence. Sulpiride was kept in the bath for 
the duration of the second session. Tubing and perfusion chamber were cleaned with 70% 
ethanol and milliQ H2O between experimental samples.
Following acquisition, imaging files were processed using ImageJ. Regions of interest 
were drawn over the FOV to include only striatal tissue and exclude the stimulation 
electrode. ROIs were kept identical across ACSF and sulpiride conditions for each slice. 
Mean fluorescence intensity for all frames was measured and exported for subsequent 
analysis in Microsoft Excel, ClampFit (Axon Instruments), and GraphPad Prism. Following 
extraction, change in raw fluorescence signal (dF) was calculated from baseline fluorescence 
(F0), which was taken as the mean intensity of the 1 second pre-stim period of each 
imaging session, and converted to percentages (dF/F0*100). dF/F0 (%) time courses were 
imported into ClampFit to analyze waveform properties. Peak and area under the curve 
(AUC) were measured in same time window in all experiments; values for each pulse 
were taken in triplicate and averaged within each experiment. When comparing dLight1.2 
signal amplitude/AUC following stimulation-evoked DA release, each value in sulpiride 
was normalized to its analogous value in ACSF conditions [i.e. 100 Hz: Peak[sulpiride]/
Peak[ACSF]. A total of 4 WT (13 slice experiments) and 3 CReP OE animals (10 
slice experiments) were used. For statistical measurement of CReP OE impact on evoked 
dLight1.2 signal, a two-way ANOVA was used; significance was set at α = 0.05. To ensure 
any observed changes in signal amplitude/AUC was not due to rundown, signal decay was 
calculated as peak dF/F0 (%) of the second single stim trial as a percent of the first signal 
stim trial for each experiment in each condition. There was no apparent signal decay in 
either condition, and calculated decay metrics were not different across groups (In ACSF: 
WT [109.8 ± 9.063 SEM, n=14] vs. CReP OE [95.52 ± 2.907 SEM, n=10], p=0.211, 
unpaired t-test. Sulpiride: WT [99.17 ± 8.668 SEM, n=14] vs. CReP OE [94.22 ± 4.498 
SEM, n=10], p = 0.657, unpaired t-test).
Morris Water Maze
For the “weak training protocol”: Mice were trained in a water pool of ~100 cm diameter 
with a hidden platform of ~10 cm diameter. Mice were handled daily for 3 days before the 
experiment, and the training protocol consisted of one swimming trial per day. Each mouse 
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should swim until it finds the hidden platform or 120 s, when it is to be gently guided to 
the platform and allowed to stay there for 10 s before being returned to the home cage. For 
the probe test, the platform is removed and each mouse is allowed to swim for 60 s, while 
its swimming trajectory is monitored with a video tracking system and analysis with Noldus 
EthoVision XT software (Noldus Information Technology Inc.; RRID: SCR_000441) (20).
Open Field
Mice were placed in an opaque 20 cm x 20 cm open field apparatus and locomotor activity 
over the course of thirty minutes in five-minute bins. Total distance traveled and velocity 
were analyzed using Digiscan analyses (Accuscan Instruments).
Operant Chamber Lever Press
Prior to the start of training, animals were food restricted over 3 days to 85–90% of their 
baseline weight to motivate learning. All animals were maintained at this restricted weight 
for the duration of their training. All training and testing occurred in Med Associates operant 
chambers housed within light-resistant, sound-attenuating cabinets (ENV-022MD). During 
each training and testing session, mice were presented with 2 levers – one lever on the 
left and one on the right of the food cup. On training days, only lever presses on the 
left lever were rewarded with sucrose-containing pellets (Bio-serv, F05684). Lever presses 
and food cup entries were recorded by Med-PC-V software (Med Associates Inc. RRID: 
SCR_012156). Food cup entries were detected by the breaking of an infrared beam inside 
the cup.
Animals were trained on the schedule described in Figure 5B. Mice started training with 
5 days of continuous reinforcement (CRF) in which each left lever press results in reward. 
CRF sessions lasted 60 minutes or until the mice received 100 reinforcers. CRF is used to 
establish the association between the left lever press action and the sucrose pellet outcome. 
After CRF, animals were trained in random interval (RI) reinforcement schedules, with 
all training sessions lasting 60 minutes or until mice received 50 reinforcers. After the 
last session of CRF, mice were given 3 sessions of random interval 30 (RI-30) schedule 
followed by 8 days of random interval 60 (RI-60) schedule. RI reinforcement resulted 
in a 10% chance that a sugar pellet would be available each X/10 seconds for a RI-X 
schedule. For example, in an RI-60 schedule, for each 6 second epoch, there was a 10% 
chance that a pellet would be delivered the next time the lever was pressed. In simpler 
terms, this means that on average one reinforcer is delivered upon the first press after 60 
seconds since the last reinforcer was given. This random interval schedule weakens the 
behavior-reward relationship, biasing the action of a lever press towards being established 
as a habit. Following RI reinforcement training, mice underwent devaluation testing with an 
extinction probe test to measure habitual behavior as previously described (41). All training 
was performed with experimenter blinded to viral expression group.
Experimental Blinding and Statistical Analysis
Sample size: Sample size used for any measurement was based on the ARRIVE 
recommendations on refinement and reduction of animal use in research. Minimal sample 
sizes were estimated based on previously published work, author’s experience, and our 
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preliminary investigations. In experiments that were repeated with different perturbations 
as in Fig. 3, power analysis was used to establish minimum group sizes. Replication: 
In all experiments, a minimum of two to three independent biological replicates of mice 
were used. All attempts at replication were successful. At the animal subject level, at least 
3 mice were used in each experimental group, with the exception of one experimental 
group with 2 mice. Replicates are fully described in manuscript to include independent 
mice and cells. Randomization: For animal studies, mice were randomized to achieve 
balance of age, sex and littermates across groups. All other experimental variables, such as 
viral type or chemical compounds were blinded and randomized across groups. Whenever 
possible, both treatment groups were tested at the same time. When both conditions were 
not possible to test on the same day, treatment groups were interleaved on alternating 
days. Blinding: The test experimental variable was blinded for all experiments reported 
to experimental group (eg genotype, genetic manipulation/virus, or drug treatment). Data 
unblinding was performed once data analysis including quality control and exclusion criteria 
assessment was completed and documented. Data exclusions: Samples or animals were 
excluded rarely (<10% of collected). Exclusions occurred for technical reasons as in the 
case of incorrect/absent stereotaxic viral targeting, inadequate fixative perfusion of animals 
impairing immuno-labeling of histological sections, or when cells in electrophysiological 
recordings did not meet pre-established exclusion criteria related to cell identity and 
recording stability. All data exclusions were made prior to unblinding. When numerical 
data were transformed to Log2 ratio in Figure 3, if no firing was detected in the post­
quinpirole period, an imputed value was used equivalent to a single event occurring (0.00166 
Hz, e.g. 1 AP in 601 s) in place of zero to avoid NaN; The number of such imputed 
values are indicated in parentheses - Fig. 3D Veh (3), ISRIB (1); Fig. 3M Cre(−) (2). 
Statistical analysis: Data shown as mean ± SEM. The evaluation of statistical differences 
was performed with nested t-tests throughout manuscript with a few exceptions noted in 
figure legends. Data acquired from immunohistochemistry studies were analyzed using 
GraphPad Prism 9.0 by two-tailed nested t-test or nested one-way ANOVA with Tukey’s 
post-hoc analysis where appropriate for p-value and F-statistic. For slice electrophysiology 
data analysis, data were acquired by pClamp v10.7 and analyzed using pClampfit v10.7 
(Molecular Device; RRID: SCR_011323), Origin 8.0 (Microcal; RRID: SCR_002815), 
Prism 9.0 (GraphPad: RRID: SCR_002798), and MATLAB R2018a (The MathWorks, Inc.; 
RRID: SCR_001622). For single-cell sequencing data analysis, differential Atf4 expression 
was evaluated by two-tailed t-test with Welch’s correction. For behavioral testing, latency 
to escape and velocity during the Morris Water Maze task, velocity during the Open Field 
test and lever press rate between experimental groups was compared by Two-way repeated 
measures ANOVA with Sidak’s post hoc test for multiple comparisons, NDLPr by unpaired 
t-test, and Inter-Press Interval by two-way Kolmogorov-Smirnov (K-S) test for probability 
distribution. For all analyses, data is shown as mean ± SEM and the significance level set at 
p < 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SPOTlight, a brain-wide reporter of ISR state-dependent translation.
(A) SPOTlight reporter design. (B) Top – Brain-wide delivery of SPOTlight reporter and 
validation strategy. Bottom – ISR schematic showing Tunicamycin and ISRIB sites of 
action. (C and D) Mid-section sagittal views of brain-wide SPOTlight EGFP (C) and 
tdTomato (D) (amplified by anti-RFP with Rhodamine Red-conjugated secondary antibody) 
expression under basal conditions. Scale bar 1000 microns. (E) A survey of the brain 
reveals rare cells in the hippocampus (scale bar 100 microns), cerebellum and striatum 
(scale bars 50 microns) with strong tdTomato signal. (F) In vivo induction of the ISR with 
acute tunicamycin (middle row) results in a robust increase in tdTomato signal compared 
to vehicle (top row), which corresponds with p-eIF2α immuno-positive soma in the CA2 
pyramidal layer of the mouse hippocampus. This increase is attenuated by pre-treatment 
with ISRIB (bottom row). Scale bar 50 microns. (G) Quantification of tdTomato signal. (Veh 
- 8 mice, 76 cells; Tm - 9 mice, 137 cells; ISRIB/Tm - 4 mice, 110 cells). Nested t-test for 
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Tm v Veh: t=3.861, F(1,15)=14.91, **p=0.0015; Tm v ISRIB/Tm: t=2.612, F(1,11)=6.823, 
*p=0.0242); and ISRIB/Tm v Veh: t=1.000, F(1,10)=1.001, p=0.3407 (ns). Treatment: 
F(3,20)= 4.788, *p=0.0113 by nested one-way ANOVA with Tukey’s post hoc test for 
multiple comparisons. (H) Quantification of mean somatic p-eIF2α corrected total cell 
fluorescence (CTCF). (Veh - 3 mice, 64 cells; Tm - 3 mice, 77 cells; ISRIB/Tm - 3 mice, 79 
cells). Nested t-test for Tm v. Veh: t=5.187, F(1,139)= 26.90, ***p=0.0001; ISRIB/Tm v Tm: 
t=4.620, F(1,154)=21.34, ***p<0.0001; and ISRIB/Tm v Veh: t=0.409, F(1,141)=0.1675, 
p=0.6830 (ns). Treatment: F(3,257)=12.19, ***p<0.0001 by nested one-way ANOVA with 
Tukey’s post hoc test for multiple comparisons.
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Figure 2. CINs show steady-state activity-dependent ISR activation.
(A) Photomicrographs of the dorsal striatum showing levels of SPOTlight EGFP and 
tdTomato (amplified by anti-RFP/Rhodamine Red) in CINs (ChAT+, top) and SPNs 
(DARPP32+, bottom). (B) Phospho-eIF2α immunofluorescence in CINs (top) and SPNs 
(bottom). (C) Quantification of p-eIF2α CTCF from (B). Images were analyzed with 
FIJI, and immunofluorescence was determined per cell and presented as the mean CTCF 
± SEM. (ChAT+ - 3 mice, 92 cells; DARPP32+ - 3 mice, 395 cells). Nested t-test, 
t=12.54, F(1,4)=157.3, ***p=0.0002. Scale bar 25 microns. (D) Strategy for Cre-mediated 
expression of hM4Di (Gi) DREADD fused to mCherry or mCherry alone in dorsal 
striatal CINs of ChAT-Cre heterozygous mice. All mice received chronic clozapine-N-oxide 
(CNO) at a dose of 3 mg/kg/day divided in two evenly spaced doses for 5 days. (E) 
Representative photomicrographs from the dorsal striatum of mCherry control (top) vs 
Gi DREADD-expressing (bottom) mice showing ChAT immunohistochemistry, mCherry 
expression, p-eIF2α immunohistochemistry with DAPI counterstain, and merged images. 
Scale bar 25 microns. (F) Quantification of p-eIF2α CTCF from (E). (mCherry control - 5 
mice, 270 ChAT+ cells; Gi DREADD - 5 mice, 215 ChAT+ cells). Nested t-test: t=4.079, 
F(1,8)=16.64, **p=0.0035.
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Figure 3. ISR state in CINs alters D2R modulation of CIN firing.
(A) ISR schematic showing pharmacological and genetic manipulations in green. (B) 
Illustration of cell-attached recording mode and representative trace displaying the normally 
observed pause in CIN firing in response to the D2R agonist quinpirole. (C) Representative 
recordings of spontaneous CIN firing before and after quinpirole addition (10 μM, 3 min) 
in brain slices pre-incubated with vehicle or 50 nM ISRIB. (D) Quantification of CIN 
firing rates, showing paired measurements before and after quinpirole (Veh - 13 mice, 29 
cells; ISRIB - 11 mice, 30 cells). Nested t-test: t=2.612, F(1,22)=6.882; *p=0.016. (E) 
Log2 modulation index of data in (D), to illustrate net directionality of D2R modulation; 
rate decreases below the abscissa and increases above it. (F) Representative recordings 
of spontaneous CIN firing before and after quinpirole (10 μM, 3 min) in brain slices 
pre-incubated with vehicle or 100 nM AMG PERK 44. (G) Quantification showing paired 
measurements before and after quinpirole (Veh - 3 mice, 8 cells; AMG PERK 44 – 3 mice, 
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10 cells). Nested t-test: t=3.563, F(1,16)=12.70; *p=0.034. (H) Log2 modulation index of 
data in panel (G). (I) Strategy for Cre-dependent expression of the p-eIF2α phosphatase 
CReP in CINs (AAV9-DIO CReP x ChAT-Cre mice). (J) Example images of ChAT 
and p-eIF2α immunohistochemistry in CINs (ChAT+ cells). Scale bar 25 microns. (K) 
Quantification of mean somatic p-eIF2α CTCF from (J). (Cre(−) - 3 mice, 109 cells; Cre(+) 
- 3 mice, 94 cells). Nested t-test: t=3.664, F(1,4)=13.42, *p=0.022. (L) Representative 
recordings of spontaneous CIN firing before and after quinpirole (10 μM, 3 min) in 
CINs over-expressing CReP. (M) Quantification of paired measurements before and after 
quinpirole (Cre(−) - 10 mice, 24 cells; Cre(+) - 9 mice, 19 cells). Nested t-test: t=2.392 
F(1,41)=5.720; *p=0.021. (N) Log2 modulation index of data in (M). #P-values of all Log2 
graphs are < 0.05. Since some of these data include imputed values to avoid NaN (See 
Materials and Methods), the reader is referred to p-value for the primary data in prior panel.
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Figure 4. CIN ISR inhibition inverts the effect of D2R modulation on evoked dopamine 
transients.
(A) Schematic illustrating viral expression of dLight1.2 reporter ± Cre-dependent 
overexpression of CReP in dorsal striatum of ChAT-Cre mice, followed by recording 
of evoked transients in acute brain slices. FOV indicates recording field of view. (B) 
Representative traces of whole-FOV striatal responses to electrically evoked dopamine 
release using a single pulse or five pulses at 2, 5, or 100Hz. Example traces are the mean of 
three responses, and are represented as % dF/F0 (percent change in baseline fluorescence). 
Control (top) and CReP-OE (bottom) conditions in ACSF (black) and 5 µM Sulpiride (red). 
(C) Mean effect of D2R modulation on the peak amplitude of evoked dLight1.2 responses, 
represented as 100 - Amplitude[Sulpiride]/Amplitude[ACSF] (%). Values are mean ± SEM. 
(Control - 4 mice, 13 slices; CReP-OE - 3 mice, 10 slices). Two-way ANOVA – significant 
effects of viral manipulation [F(1,21) = 16.15, p<0.001] and pulse number [F(1.302, 27.34) 
= 5.117, p<0.05], and a significant interaction [F(3,63) = 4.237, p<0.01]. (D) Mean effect of 
D2R modulation on the area under the curve (AUC) of evoked dLight1.2 responses. Values 
are mean ± SEM. (Control - 4 mice, 13 slices; CReP-OE - 3 mice, 10 slices). Two-way 
ANOVA – significant effects of viral manipulation [F(1,21) = 10.87, p<0.01] and pulse 
number [F(2.173, 45.64) = 4.730, p<0.05], but no interaction [F(3,63) = 1.37, p=0.26].
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Figure 5. CIN ISR inhibition enhances performance vigor of learned tasks.
(A) Schematic illustrating viral expression of mCherry tracer ± Cre-dependent CReP 
overexpression in dorsal striatum of ChAT-Cre mice (left), followed three weeks later by 
testing in the Morris water maze (center), operant chamber lever press task (right), and open 
field (not shown). (B) Results of Morris water maze training. Male ChAT-Cre heterozygous 
mice with CReP OE in dorsal striatal CINs (blue) reached the hidden platform faster than 
controls (black; mCherry virus alone) over the course of training in a modified Morris water 
maze protocol as used in 2,29. (4 mice per group). *p=0.0106 by two-way rmANOVA with 
Bonferonni’s post-hoc test F(7,42)=3.068. (C) Results of lever press training. Cre-dependent 
CReP OE mice (blue) achieved higher lever press rates than control mice (black; mCherry 
virus alone) in a randomized interval (RI) training protocol using increasing mean time 
delays before reward delivery. (10 mice per group). Two-way ANOVA with Sidak’s multiple 
comparisons test: F(15,270)=3.776, *p< 0.0001. CRF – continuous reinforcement; RI-30 
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– random interval, 30s average delay; RI-60 – random interval, 60s average delay. (D) 
Normalized devalued lever press rate (NDLPr), a measure of habit learning, was not affected 
by CIN CReP overexpression. (10 mice per group; p=0.69). (E) Cumulative probability 
distribution showing CReP OE mice (blue) pressed with shorter intervals between presses 
than controls (black) on the final day of lever press training. (Control - 7 mice, 5,797 events; 
CReP OE - 7 mice, 10,841 events; data for 3 mice in each cohort was lost due to instrument 
failure). *p<0.0001 by two sample Kolmogorov-Smirnov test. (F) Mean swimming velocity 
of mice with CReP OE (blue) exceeded that of mCherry controls (black) during the Morris 
water maze task. (4 mice per group). Two-way rmANOVA: F(6,42)=4.981, **p=0.0006. (G) 
CReP OE mice show no differences in locomotor speed during exploration of a novel open 
field chamber. (10 mice per group). Two-way ANOVA: F(5,90)=1.645, p=0.1563. All data 
are presented as mean ± SEM.
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